A study by Massoumi et al. used genetically‐engineered mouse models and demonstrated that the loss of a single copy of the CYLD gene was sufficient to confer a multiple tumor phenotype upon chemical compound‐induced mice. The gene discussed is CYLD; the disease is neoplasm.